Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
نویسندگان
چکیده
Myxoid liposarcoma is a rare form of soft-tissue sarcoma. Although most patients initially respond well to treatment, approximately 21% relapse, highlighting the need for alternative treatments. To identify novel treatment regimens and gain a better understanding of myxoid liposarcoma tumor biology, we screened various candidate and approved targeted therapeutics and chemotherapeutics against myxoid liposarcoma cell lines. Therapeutics that target angiogenesis showed antitumor activity. The small molecule inhibitor axitinib, which targets angiogenesis by inhibiting the VEGFR and PDGFR families and c-Kit, inhibited cell cycle progression and induced apoptosis in vitro, as well as having significant antitumor activity against MLS 1765 myxoid liposarcoma xenografts in mice. Axitinib also displayed synergistic antitumor activity in vitro when combined with the potassium channel ionophore salinomycin or the BH3 mimetic ABT-737. Another angiogenesis-targeting therapeutic, 4EGI-1, which targets the oncoprotein eIF4E, significantly decreased angiogenic ligand expression by myxoid liposarcoma cells and reduced tumor cell growth. To verify this oncogenic addiction to angiogenic pathways, we utilized VEGFR-derived ligand traps and found that autocrine VEGFR signaling was crucial to myxoid liposarcoma cell survival. Overall, these findings suggest that autocrine angiogenic signaling through the VEGFR family is critical to myxoid liposarcoma cell survival and that further study of axitinib as a potential anticancer therapy is warranted.
منابع مشابه
Multicentric Myxoid Liposarcoma; a Case Report and Literature Review
Liposarcoma is a common malignant soft tissue tumor, accounting for 10% to 16% of all sarcomas. Multicentric myxoid liposarcoma is an uncommon condition. Differentiation between several primary tumors and metastasis of a single liposarcoma represents the main difficulty in diagnosis. A 47-years old woman presented with right thigh myxoid liposarcoma and underwent wide margin tumor resection. ...
متن کاملSignificant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib
INTRODUCTION Myxoid/round cell liposarcoma is the second most common subtype of liposarcoma. Chemotherapy and radiotherapy have a limited efficacy for treating advanced myxoid/round cell liposarcoma, with relatively serious side effects. CASE PRESENTATION We herein present a 68-year-old Chinese woman initially diagnosed with advanced multiple intra-abdominal and pelvic round cell liposarcoma....
متن کاملبررسی جنبه های اپیدمیولوژیک و پاتولوژیک لیپوسارکوم در بیمارستان های دانشگاهی شهر مشهد در طی ده سال
Background and Aim: Liposarcoma is one of the most common soft tissue sarcomas in adults, ranging in incidence from 9.8% to 16%, which is recognized through the presence of lipoblast cells. It reaches its peak incidence during the fifth and seventh decades of life in males. It develops predominantly in the lower extremity and retroperitoneum; also, there are some other uncommon localizations as...
متن کاملel Models of Myxoid Liposarcoma Xenografts Mimicking Biological and Pharmacologic Features of R an Tumors
Download pose: Myxoid liposarcoma is a common subtype of liposarcoma. It is associated in more than 90% es with the chromosomal translocation t(12;16)(q13;p11) leading to the fusion FUS-CHOP gene responsible for the oncogenic transformation of preadipocytes. Recently the marine natural prodbectedin has shown highly selective activity for myxoid liposarcoma, even in the most aggressive -cell sub...
متن کاملModels of Myxoid Liposarcoma Xenografts Mimicking Biological and Pharmacologic Features of R an Tumors
Downloa pose: Myxoid liposarcoma is a common subtype of liposarcoma. It is associated in more than 90% es with the chromosomal translocation t(12;16)(q13;p11) leading to the fusion FUS-CHOP gene responsible for the oncogenic transformation of preadipocytes. Recently the marine natural prodbectedin has shown highly selective activity for myxoid liposarcoma, even in the most aggressive -cell subt...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 2016 شماره
صفحات -
تاریخ انتشار 2016